Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy
NCT02271893Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Dextromethorphan with Placebo (2 arms). Primary endpoint: Average pain intensity by a numerical rating scale at 1 month. Started Nov 2014; status: terminated.
02
Drugs
dextromethorphan
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT02271893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271893.